NREP
NEW REPRESENTATIVE AT IB RECEIVED
04/07/2025
Voltar para busca
Dado oficial do USPTO
PROPOCARE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
33
Atualização mais recente
03/04/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 30
Data de depósito
30/01/2023
Data de registro
08/10/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
08/10/2024
Última transação
03/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
GB
Examinador
KAPLAN, VALERIE ELIZABETH
Unidade examinadora
L70
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
TLC - Tender Loving Care UK Ltd
Representantes
David Simonelli Simonelli IP, PLLC
Classificação técnica
Classes Nice
Classe 5Classe 30
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Nutritional and food supplements; vitamin and mineral supplements; breath-freshening chewing gum for medicinal purposes; gummy vitamins; medicated sweets; sweets for medical purposes; pharmaceutical sweets; medicated lozenges; herbal honey throat lozenges; lozenges for pharmaceutical purposes; nicotine-containing lozenges for medical use; syrups being medicines for the treatment of coughsflusore throats and flu like symptomscold sorescoldsother respiratory conditionsallergies and allergy symptomsheadacheschest congestionoral woundsminor woundspain relieversmedicinal syrups containing analgesicsspecifically acetaminophen and ibuprofen used to relieve pain and reduce feversyrups being medicines to boost the immune system of the babieschildren and adultsanti-viral syrupssyrups containing vitamins and ingredients derived from beehives with antiviralanti-bacterialantimicrobial and anti-fungal action; syrups for pharmaceutical purposes for the treatment of coughsflusore throats and flu like symptomscold sorescoldsother respiratory conditionsheadacheschest congestionoral woundsminor woundspain relieversfor the treatment of stomach acid and relieve heartburn and indigestionvitamin and mineral deficiencies; propolis dietary supplements; dietary supplemental drinksnamely vitamin drinks; vitamin fortified beverages for medical purposes; vitamin enriched water for medical purposes; liquid herbal supplements; liquid nutritional supplements; liquid vitamin supplements; propolis for pharmaceutical purposes.
Classe 30
Gummy candies; chewing gums; gummy sweets; sweets; candies; ginseng sweets; non-medicated sweets; non-medicated lozenges; syrups for making teaflavored beveragescandiessaucessyrups to sweeten ice cream and sorbetsfruit syrups used in the making of preserves and jamsfor making foodagave syrup and glucose syrups for fooddate syruppowdered starch syrupstarch syrup for culinary purposesmolasses syrup for culinary purposescorn syrup for culinary purposesagave syrup for use as a natural sweetenercorn syrup; yacon syrupchocolate syrup and treacles; table syrup; topping syrups; liquid sugar; extractsother than essential oilsfor flavoring beverages; propolisnamely bee glue for human consumption.
Publicações
Histórico de despachos e eventos da marca no USPTO.
33 publicações encontradas
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/04/2025
FICS
FINAL DISPOSITION NOTICE SENT TO IB
16/03/2025
FIMP
FINAL DISPOSITION PROCESSED
16/03/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/01/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/10/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
08/10/2024
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
20/09/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/09/2024
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
04/09/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
23/07/2024
PUBO
PUBLISHED FOR OPPOSITION
23/07/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/07/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
17/06/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
14/06/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
14/06/2024
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
14/06/2024
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
01/06/2024
GNFR
FINAL REFUSAL E-MAILED
01/06/2024
CNFR
FINAL REFUSAL WRITTEN
01/06/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
29/04/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
29/04/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
29/04/2024
RFNP
REFUSAL PROCESSED BY IB
28/11/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/11/2023
RFRR
REFUSAL PROCESSED BY MPU
07/11/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/11/2023
CNRT
NON-FINAL ACTION WRITTEN
03/11/2023
DOCK
ASSIGNED TO EXAMINER
27/10/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
09/06/2023
MAFR
APPLICATION FILING RECEIPT MAILED
14/04/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/04/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/04/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace PROPOCARE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.